Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High coagulation factor VIII and von Willebrand factor in patients with lymphoma and leukemia.

International journal of hematology - 1 Feb 2016

Mohren Martin, Jentsch-Ullrich Kathleen, Koenigsmann Michael, Kropf Siegfried, Schalk Enrico, Lutze Gerd

Abstract excerpt

The risk of venous thromboembolism is increased in patients with lymphoma and leukemia; however, little is known about the potential underlying hereditary or acquired thrombophilia. We prospectively analyzed procoagulant markers and gene mutations in patients with lymphoma (n = 35) and leukemia (n = 10) at diagnosis and over the course of treatment. Global coagulation tests were normal in all patients, as were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Coagulation Tests
Share to Factor V

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Factor VIII

Share to Leukemia

Share to Lymphoma

Share to Prothrombin

Share to Venous Thromboembolism

Share to von Willebrand Factor

Source

Identifiers

PMID: 26612425
DOI: 10.1007/s12185-015-1913-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High coagulation factor VIII and von Willebrand factor in patients with lymphoma and leukemia.PMID 26612425Read ↗

Hypercoagulability and Tissue Factor Gene Upregulation in Hematologic MalignanciesSemantic proximity Read ↗

Thrombophilia and cancer.Semantic proximity Read ↗

Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors.Semantic proximity Read ↗

Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status.Semantic proximity Read ↗

The risk factors for thrombosis in children with acute lymphoblastic leukemia.Semantic proximity Read ↗

Acquired activated protein C resistance is common in cancer patients and is associated with venous thromboembolism.Semantic proximity Read ↗

Inherited prothrombotic risk factors in Turkish children with acute lymphoblastic leukemia: significance of concomitant genetic mutation.Semantic proximity Read ↗

The factor V Leiden mutation in children with cancer and thrombosis.Semantic proximity Read ↗

Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial.Semantic proximity Read ↗

Incorporating genetic and clinical data into the prediction of thromboembolism risk in patients with lymphoma.Semantic proximity Read ↗

Prophylactic therapy with enoxaparin in children with acute lymphoblastic leukemia and inherited thrombophilia during L-asparaginase treatment.Semantic proximity Read ↗

Thrombotic complications during cancer treatment in children.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.